These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 21763370)
21. Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632. van Beuge MM; Prakash J; Lacombe M; Post E; Reker-Smit C; Beljaars L; Poelstra K Pharm Res; 2011 Aug; 28(8):2045-54. PubMed ID: 21442374 [TBL] [Abstract][Full Text] [Related]
22. Improved synthesis of daunomycin conjugates with triplex-forming oligonucleotides. The polypurine tract of HIV-1 as a target. Capobianco ML; De Champdoré M; Arcamone F; Garbesi A; Guianvarc'h D; B Arimondo P Bioorg Med Chem; 2005 May; 13(9):3209-18. PubMed ID: 15809156 [TBL] [Abstract][Full Text] [Related]
23. Use of polyethylenimine-adenovirus complexes to examine triplex formation in intact cells. Hoque AT; Sedelnikova OA; Luu AN; Swaim WD; Panyutin IG; Baum BJ Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):229-41. PubMed ID: 10984117 [TBL] [Abstract][Full Text] [Related]
24. Triplex-forming oligonucleotides as potential tools for modulation of gene expression. Rogers FA; Lloyd JA; Glazer PM Curr Med Chem Anticancer Agents; 2005 Jul; 5(4):319-26. PubMed ID: 16101484 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of T7 RNA polymerase transcription by phosphate and phosphorothioate triplex-forming oligonucleotides targeted to a R.Y site downstream from the promoter. Alunni-Fabbroni M; Manfioletti G; Manzini G; Xodo LE Eur J Biochem; 1994 Dec; 226(3):831-9. PubMed ID: 7813472 [TBL] [Abstract][Full Text] [Related]
27. CREKA-modified liposomes target activated hepatic stellate cells to alleviate liver fibrosis by inhibiting collagen synthesis and angiogenesis. Li R; Zhang J; Liu Q; Tang Q; Jia Q; Xiong Y; He J; Li Y Acta Biomater; 2023 Sep; 168():484-496. PubMed ID: 37392933 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of transcription by platinated triplex-forming oligonucleotides. Graham MK; Miller PS J Biol Inorg Chem; 2012 Dec; 17(8):1197-208. PubMed ID: 22965663 [TBL] [Abstract][Full Text] [Related]
29. Delivery of viral vectors to hepatic stellate cells in fibrotic livers using HVJ envelopes fused with targeted liposomes. Adrian JE; Kamps JA; Poelstra K; Scherphof GL; Meijer DK; Kaneda Y J Drug Target; 2007 Jan; 15(1):75-82. PubMed ID: 17365276 [TBL] [Abstract][Full Text] [Related]
30. Prevention of liver fibrosis by triple helix-forming oligodeoxyribonucleotides targeted to the promoter region of type I collagen gene. Koilan S; Hamilton D; Baburyan N; Padala MK; Weber KT; Guntaka RV Oligonucleotides; 2010 Oct; 20(5):231-7. PubMed ID: 20818932 [TBL] [Abstract][Full Text] [Related]
31. Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model. Luk JM; Zhang QS; Lee NP; Wo JY; Leung PP; Liu LX; Hu MY; Cheung KF; Hui CK; Lau GK; Fan ST Liver Int; 2007 May; 27(4):548-57. PubMed ID: 17403195 [TBL] [Abstract][Full Text] [Related]
32. Regulation of transcription through light-activation and light-deactivation of triplex-forming oligonucleotides in mammalian cells. Govan JM; Uprety R; Hemphill J; Lively MO; Deiters A ACS Chem Biol; 2012 Jul; 7(7):1247-56. PubMed ID: 22540192 [TBL] [Abstract][Full Text] [Related]
33. Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice. van Beuge MM; Prakash J; Lacombe M; Gosens R; Post E; Reker-Smit C; Beljaars L; Poelstra K J Pharmacol Exp Ther; 2011 Jun; 337(3):628-35. PubMed ID: 21383021 [TBL] [Abstract][Full Text] [Related]
34. Corona-directed nucleic acid delivery into hepatic stellate cells for liver fibrosis therapy. Zhang Z; Wang C; Zha Y; Hu W; Gao Z; Zang Y; Chen J; Zhang J; Dong L ACS Nano; 2015 Mar; 9(3):2405-19. PubMed ID: 25587629 [TBL] [Abstract][Full Text] [Related]
35. Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell. Greupink R; Bakker HI; Reker-Smit C; van Loenen-Weemaes AM; Kok RJ; Meijer DK; Beljaars L; Poelstra K J Hepatol; 2005 Nov; 43(5):884-92. PubMed ID: 16083988 [TBL] [Abstract][Full Text] [Related]
36. Targeted correction of an episomal gene in mammalian cells by a short DNA fragment tethered to a triplex-forming oligonucleotide. Chan PP; Lin M; Faruqi AF; Powell J; Seidman MM; Glazer PM J Biol Chem; 1999 Apr; 274(17):11541-8. PubMed ID: 10206960 [TBL] [Abstract][Full Text] [Related]
37. A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rats. Adrian JE; Kamps JA; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Terpstra P; Poelstra K Biochim Biophys Acta; 2007 Jun; 1768(6):1430-9. PubMed ID: 17493581 [TBL] [Abstract][Full Text] [Related]
38. Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA). Beljaars L; Olinga P; Molema G; de Bleser P; Geerts A; Groothuis GM; Meijer DK; Poelstra K Liver; 2001 Oct; 21(5):320-8. PubMed ID: 11589768 [TBL] [Abstract][Full Text] [Related]
39. Targeting of the HIV-1 long terminal repeat with chromomycin potentiates the inhibitory effects of a triplex-forming oligonucleotide on Sp1-DNA interactions and in vitro transcription. Bianchi N; Rutigliano C; Passadore M; Tomassetti M; Pippo L; Mischiati C; Feriotto G; Gambari R Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):919-27. PubMed ID: 9307046 [TBL] [Abstract][Full Text] [Related]
40. Chemical modification of interleukin-10 with mannose 6-phosphate groups yields a liver-selective cytokine. Rachmawati H; Reker-Smit C; Lub-de Hooge MN; van Loenen-Weemaes A; Poelstra K; Beljaars L Drug Metab Dispos; 2007 May; 35(5):814-21. PubMed ID: 17312017 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]